A type III CRISPR ancillary ribonuclease degrades its cyclic oligoadenylate activator (2019)

First Author: Athukoralage J

Attributed to: Cyclic oligoadenylate signalling - a new type of antiviral response funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/582114

Publication URI: http://dx.doi.org/10.1101/582114

Type: Preprint